CSIMarket Company Name, Ticker, Suppliers, else..
 

Bioxytran Inc   (BIXT)

Bioxytran Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

BIXT Sales vs. its Competitors Q2 2026


Comparing the current results to its competitors, Bioxytran Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, slower than the combined decrease of the BIXT's competitors by -38.5 %, recorded in the same quarter.

• List of BIXT Competitors





Revenue Growth Comparisons




Net Income Comparison

Bioxytran Inc recorded a net loss, as well as most of its competitors.

<<  BIXT Stock Performance Comparisons


Bioxytran Inc 's Comment on Competition and Industry Peers


The company operates in a rapidly changing and competitive market for its proposed products. Its competitive position relies on the protection of its intellectual property, with plans to submit additional patents and provisional patents to enhance this protection. The company may face costly and time-consuming litigation to protect or enforce its patents or other intellectual property rights. Regulatory approvals are required to commercialize its products as drugs. As a public company, it must implement additional finance and accounting systems, which will increase costs. The loss of key executives could negatively impact operations and results.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Bioxytran Inc




Adlai Nortye Ltd
Share Performance



+801.74%
One Year
Adlai Nortye Ltd
Profile

Adlai Nortye Ltd. is a holding company incorporated in the Cayman Islands, with subsidiaries operating in the United States and China.

More about Adlai Nortye Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,487.772 mill. $ 6.472 mill. $ -35.528 mill.


Novabridge Biosciences
Share Performance



-61.30%
One Year
Novabridge Biosciences
Profile

The company develops drug candidates and conducts related research and development activities in China.

More about Novabridge Biosciences's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 170.461 mill. $ - mill. $ -88.340 mill.


Whitehawk Therapeutics Inc
Share Performance



-7.77%
30 Days
Whitehawk Therapeutics Inc
Profile

The company is a clinical-stage oncology therapeutics firm focused on developing antibody-drug conjugates for cancer treatment.

More about Whitehawk Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 363.870 mill. $ 1.469 mill. $ -79.831 mill.


Ibio inc
Share Performance



+2.36%
Over The Past 5 Days
Ibio inc
Profile

Ibio Inc is a plant-based biologics company that focuses on the development and manufacturing of therapeutic proteins. They utilize their proprietary plant-based expression system to produce biotherapeutics quickly and cost-effectively. By leveraging their platform, Ibio aims to address unmet medical needs and provide affordable and accessible treatments to patients worldwide.

More about Ibio inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 135.278 mill. $ - mill. $ -33.044 mill.


Nextcure Inc
Share Performance



-36.60%
This Year
Nextcure Inc
Profile

NextCure Inc is a biopharmaceutical company that operates with a unique business model. They focus on discovering and developing novel immunomedicines to treat various forms of cancer and other immune-related diseases. With a focus on developing innovative therapies that target immune cells, NextCure aims to provide effective and personalized treatment options for patients in need.

More about Nextcure Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 44.708 mill. $ - mill. $ -42.748 mill.

33 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Bioxytran Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bioxytran Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.